Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.6 GBX | 0.00% | 0.00% | -8.57% |
Mar. 26 | Scancell doses first patient in melanoma-focused trials | AN |
Mar. 22 | Seneca Growth Capital announces tepid 2023 results | AN |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-8.57% | 98.34M | |
+1.52% | 42.59B | |
+8.39% | 40.65B | |
+49.22% | 40.57B | |
-12.36% | 26.77B | |
+8.38% | 24.81B | |
-24.42% | 18.17B | |
+28.72% | 12.05B | |
-3.41% | 11.7B | |
+6.61% | 11.1B |
- Stock Market
- Equities
- SCLP Stock
- News Scancell Holdings plc
- Update: Scancell Climbs 15% as It Selects COVID-19 Vaccine Candidate for Development, Clinical Trials